MedPath

Endovascular treatmenT for Acute Ischemic Stroke in China (DETECT2-China)

Completed
Conditions
Stroke, Ischemic
Registration Number
NCT05092139
Lead Sponsor
General Hospital of Shenyang Military Region
Brief Summary

This is a prospective real world registry study, aiming to explore the effectiveness and safety of endovascular treatment of acute ischemic stroke in a Chinese population.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3000
Inclusion Criteria
  • Age: ≥ 18;
  • Ischemic stroke confirmed by head CT or MRI;
  • Patients receiving endovascular treatment;
  • First ever stroke or pre-stroke mRS≤2;
  • signed informed consent.
Exclusion Criteria
  • Prestroke mRS≥3;
  • Other serious illness that would confound the clinical outcome at 90 days;
  • Unavailable neuroimaging data;
  • Other unsuitable conditions judged by the investigator

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proportion of patients with modified Rankin Score 0 to 2Day 90

the minimum and maximum values of modified Rankin Score are 0 and 6, respectively; higher score mean a worse outcome

Secondary Outcome Measures
NameTimeMethod
Proportion of death7 days

death due to any cause

Proportion of patients with modified Rankin Score 0 to 1Day 90

the minimum and maximum values of modified Rankin Score are 0 and 6, respectively; higher score mean a worse outcome

Distribution of modified Rankin ScoreDay 90

the minimum and maximum values of modified Rankin Score are 0 and 6, respectively; higher score mean a worse outcome

Proportion of symptomatic intracranial hemorrhage (sICH)48 hours

sICH was defined as 4 or more increase in NIHSS caused by hemorrhage

Changes in National Institute of Health stroke scale (NIHSS)24 hours, 48 hours, and 2 weeks

the minimum and maximum values of NIHSS are 0 and 24, respectively; higher NIHSS mean a worse outcome

Trial Locations

Locations (1)

Hui-Sheng Chen

🇨🇳

ShenYang, Liaoning, China

© Copyright 2025. All Rights Reserved by MedPath